Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Bratton Capital Management, L.P. | 9.81M | $40.0M | 7.89% | -- | 2026-03-31 |
| BlackRock, Inc. | 7.51M | $31.0M | 6.04% | -266.3K | 2026-03-31 |
| RTW INVESTMENTS, LP | 7.43M | $30.0M | 5.98% | +1.18M | 2026-03-31 |
| FEDERATED HERMES, INC. | 2.94M | $12.0M | 2.37% | +907.5K | 2026-03-31 |
| Balyasny Asset Management L.P. | 2.90M | $12.0M | 2.33% | +1.93M | 2026-03-31 |
| STATE STREET CORP | 2.55M | $10.0M | 2.05% | +83.4K | 2026-03-31 |
| SAMSARA BIOCAPITAL, LLC | 2.50M | $10.0M | 2.01% | -- | 2026-03-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.41M | $9.0M | 1.94% | +40.1K | 2026-03-31 |
| BANK OF AMERICA CORP /DE/ | 2.41M | $9.0M | 1.94% | +1.20M | 2026-03-31 |
| Sio Capital Management, LLC | 1.92M | $7.0M | 1.55% | +929.8K | 2026-03-31 |
